The Journal of Infection in Developing Countries · 2015 · 93 citations · 7 references
Life SciencesInfectious DiseasesMicrobiologyAntimicrobial ResistanceMedical MicrobiologyMicrobial PathogenesisAntifungal AgentsAntifungal ResistanceAntifungal TherapyFungal DiagnosticsFungal InfectionsFungal PathogenesisAntifungal AntibioticsAntifungal Susceptibility TestingAntifungal TreatmentsCandida Albicans InfectionCandida Auris ResistanceFluconazole TherapyNon-albicans Candida SpeciesVulvovaginal Candidiasis Treatment
Since the emergence of pathogenic non-albicans Candida species, a number of new isolates have been added to the list. One such unusual species is Candida auris (C. auris), recently isolated and studied in few reports. In this study, a case of vulvovaginitis caused by Candida auris incidentally identified by molecular methods using internal transcribed spacer polymerase chain reaction (ITS PCR) is described. Antifungal susceptibility testing revealed the isolate to be resistant to itraconazole (MIC ≥ 2 µg/ml) and expressed important virulence factors including phospholipase, proteinase and hemolysin activity. The patient was successfully treated with oral fluconazole and did not have any invasive fungemia. Very few cases of this emerging pathogen have been reported. However, its isolation from clinical specimens reveals the significance of non-albicans candida species over C. albicans and the diversity of Candida spp causing infections.
7
First Three Reported Cases of Nosocomial Fungemia Caused by Candida auris
Wee Gyo Lee, Jong Hee Shin, Young Uh et al. · Journal of Clinical Microbiology · 2011 · 522 citations · Full text
Mi‐Na Kim, Jong Hee Shin, Heungsup Sung et al. · Clinical Infectious Diseases · 2009 · 304 citations · Full text
Prevalence & susceptibility to fluconazole of Candida species causing vulvovaginitis.
Srujana Mohanty, Immaculata Xess, Arti Kapil et al. · PubMed · 2007 · 91 citations